Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Intel
INTC
|
+$1.27B |
| 2 |
Dominion Energy
D
|
+$747M |
| 3 |
Otis Worldwide
OTIS
|
+$574M |
| 4 |
Microsoft
MSFT
|
+$555M |
| 5 |
Merck
MRK
|
+$524M |
Top Sells
| 1 |
RTX Corp
RTX
|
+$579M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$478M |
| 3 |
Philip Morris
PM
|
+$425M |
| 4 |
Aptiv
APTV
|
+$407M |
| 5 |
Marriott International Class A Common Stock
MAR
|
+$399M |
Sector Composition
| 1 | Technology | 22.06% |
| 2 | Financials | 17.71% |
| 3 | Healthcare | 15.83% |
| 4 | Industrials | 13.15% |
| 5 | Communication Services | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Azenta
AZTA
$1.35B
| $14.9M | 0.01% |
336,183
-9,072
| -3% | -$401K |
|
|
SASR
577
DELISTED
Sandy Spring Bancorp Inc
SASR
| $14.7M | 0.01% |
593,916
+81,715
| +16% | +$2.02M |
|
578
Patterson-UTI
PTEN
$2.11B
| $14.5M | 0.01% |
4,185,687
-5,268,770
| -56% | -$18.3M |
|
579
Teladoc Health
TDOC
$1.33B
| $14.3M | 0.01% |
74,816
-35,877
| -32% | -$6.85M |
|
580
HealthEquity
HQY
$7.89B
| $14.2M | 0.01% |
241,570
-206,176
| -46% | -$12.1M |
|
581
Neurocrine Biosciences
NBIX
$14B
| $14.2M | 0.01% |
116,077
-13,205
| -10% | -$1.61M |
|
582
BridgeBio Pharma
BBIO
$10.2B
| $13.9M | 0.01% |
425,321
+32,613
| +8% | +$1.06M |
|
583
SAP
SAP
$303B
| $13.3M | 0.01% |
95,043
+441
| +0.5% | +$61.7K |
|
584
Vroom, Inc. Common Stock
VRM
$135M
| $13M | 0.01% |
+3,110
| New | +$13M |
|
585
Cars.com
CARS
$816M
| $12.6M | 0.01% |
2,181,778
| – | – |
|
|
DHR.PRA
586
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $12.6M | 0.01% |
10,068
-35
| -0.3% | -$43.6K |
|
|
FPI
587
Farmland Partners
FPI
$471M
| $12.4M | ﹤0.01% |
1,817,271
-203,273
| -10% | -$1.39M |
|
588
Globant
GLOB
$2.51B
| $12.3M | ﹤0.01% |
81,826
+21,606
| +36% | +$3.24M |
|
589
Levi Strauss
LEVI
$8.56B
| $12M | ﹤0.01% |
897,537
+118,257
| +15% | +$1.58M |
|
590
10x Genomics
TXG
$1.57B
| $12M | ﹤0.01% |
134,208
+10,907
| +9% | +$974K |
|
591
CVS Health
CVS
$93.7B
| $12M | ﹤0.01% |
184,184
-52,814
| -22% | -$3.43M |
|
592
Collegium Pharmaceutical
COLL
$1.19B
| $11.7M | ﹤0.01% |
666,918
+183,352
| +38% | +$3.21M |
|
593
WEC Energy
WEC
$35.2B
| $11.7M | ﹤0.01% |
133,132
-274,019
| -67% | -$24M |
|
|
PRNB
594
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $11.7M | ﹤0.01% |
194,969
+9,313
| +5% | +$557K |
|
|
OPTN
595
DELISTED
OptiNose
OPTN
| $11.6M | ﹤0.01% |
103,979
+8,165
| +9% | +$911K |
|
596
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.9B
| $11.5M | ﹤0.01% |
437,014
-557,817
| -56% | -$14.7M |
|
597
VeriSign
VRSN
$26.5B
| $11.5M | ﹤0.01% |
55,397
-34,762
| -39% | -$7.19M |
|
598
Mattel
MAT
$5.76B
| $11.3M | ﹤0.01% |
+1,168,461
| New | +$11.3M |
|
599
Eagle Materials
EXP
$7.51B
| $11.3M | ﹤0.01% |
160,529
-16,793
| -9% | -$1.18M |
|
600
Berkshire Hathaway Class B
BRK.B
$1.06T
| $11M | ﹤0.01% |
61,426
-36,800
| -37% | -$6.57M |
|